Kiromic BioPharma
高管
查看带有其 7 名主要高管的组织结构图
Kiromic BioPharma 搜索最多的简介
- Pietro Bersani, Chief Executive Officer and Director
- Pamela Misajon, Director
- Michael Catlin, Director
创建提醒
跟踪 Kiromic BioPharma 的高管变动
生物技术
Kiromic BioPharma 拥有 2,326 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
- Trace Neuroscience 刚刚宣布为 101 筹款数百万美元。 (公布2024十一月14号).
- AvenCell Therapeutics 刚刚宣布为 112 筹款数百万美元。 (公布2024十一月11号).
生物技术 行业的其他推荐联系人
消息
Kiromic BioPharma 的最新新闻稿
- Kiromic BioPharma Appoints Leonardo Mirandola, Ph.D. as Chief Scientific Officer | Kiromic BioPharma, Inc.
- Kiromic BioPharma Achieves Milestone with Timely Completion of Expanded cGMP Manufacturing Facility to Support Cell Therapy Oncology Pipeline | Kiromic BioPharma, Inc.
- Kiromic BioPharma Pipeline to Prioritize a New Gamma Delta T-cell Product Candidate | Kiromic BioPharma, Inc.
- Kiromic BioPharma Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement | Kiromic BioPharma, Inc.
- Kiromic BioPharma Reports First Quarter 2022 Financial Results and Recent Corporate Highlights | Kiromic BioPharma, Inc.
- Kiromic BioPharma Announces Company Will Directly Submit Amended IND for Procel™ to the FDA in Second Half of 2022 | Kiromic BioPharma, Inc.
- Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights - Kiromic BioPharma, Inc.
- Kiromic Announces the Acquisition of InSilico Solutions Leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors - Kiromic BioPharma, Inc.
- Kiromic BioPharma Provides Update on IND Filings on its Off-the-Shelf, Allogeneic CAR-T for Solid Tumors - Kiromic BioPharma, Inc.
- Kiromic BioPharma, Inc. Announces Closing of Public Offering - Kiromic BioPharma, Inc.
- View more press releases Close
通过电子邮件
